If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptima Health Regulatory News (OPT)

Share Price Information for Optima Health (OPT)

Share Price is delayed by 15 minutes
Get Live Data
191.00    0.00 (0.00%)
Bid:
190.00
Ask:
192.00
Spread: 2.00 (1.053%)
Market Cap: £207.76m
OPT Live PriceLast checked at - London Stock Exchange

Intraday Optima Health Share Chart

Full Year Trading Update

17 Apr 2026 07:00

RNS Number : 9162A
Optima Health PLC
17 April 2026
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

17 April 2026

Optima Health plc

("Optima", the "Company", and, together with its subsidiaries, the "Group")

Full Year Trading Update

Full year adjusted EBITDA expected to be c.10% ahead of market expectations

Optima Health (AIM: OPT), the UK's leading provider of technology enabled corporate health and wellbeing solutions, today announces an unaudited trading update for the year ended 31 March 2026.

Further to the previously communicated commentary on current trading announced on 31 March 2026, Optima now expects FY26 Adjusted EBITDA to be ahead of market expectations[1] by c.10%.

Optima has continued to make strong progress against its strategic objectives and medium-term targets of £200 million revenue and £40 million adjusted EBITDA. The recent acquisition of PAM, which completed on 26 March 2026, positions the enlarged Group to capitalise on the growing market opportunity, whilst benefiting from significant operational and cost synergies which will help Optima achieve its medium-term EBITDA target.

The previously disclosed procurement matter has now been settled. Other operating income of £2.3 million was recognised in H1 FY26, and a further £2.4 million has been recognised in H2 FY26.

A full trading update will be made later in Q2 2026.

Jonathan Thomas, Chief Executive Officer, said: "Optima's strong financial performance in H2, ahead of market expectations, reflects the consistent progress we have continued to make against our strategic objectives. The recent transformational acquisition of PAM has further solidified Optima's position in the attractive and growing occupational health market. We look forward to increasing our presence in our core markets, alongside seeking new opportunities, as we continue to accelerate growth."

 

Enquiries

Optima Health

Jonathan Thomas, CEO

Heidi Giles, CFO

 

+44(0)3300085113

media@OptimaHealth.co.uk

Panmure Liberum Limited

Nominated Adviser and Corporate Broker

Emma Earl / Will Goode/ Mark Rogers

Rupert Dearden

 

+44 (0)20 3100 2000

 

Cavendish Capital Markets

Joint Broker

Geoff Nash/Ben Jeynes/George Lawson

Julian Morse/Michael Johnson/Nigel Birks

 

+ 44 (0)20 7220 0500

ICR Healthcare

UK Financial PR Adviser

Mary-Jane Elliott / Angela Gray / Lindsey Neville

optimahealth@icrinc.com

 

 

About Optima Health

Optima Health is the UK's leading provider of occupational health and wellbeing services, delivering clinically led, technology-driven solutions to organisations across the public and private sectors. With a team of more than 2,000 including 1,250 clinicians, Optima Health supports millions of employees and operates from a network of more than 50 clinics nationwide.

 In addition to its core UK market, Optima Health also operates in Ireland under Optima Health Ireland, providing occupational health services to clients nationwide.

 

For more information visit www.optimahealth.co.uk

 


[1] FY26 adjusted EBITDA market consensus £18.1 million

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUBVVRNRUSARR
Date   Source Headline
12th Mar 20097:00 amRNSOPT third quarter and nine months 2009 results
5th Mar 20097:00 amRNSOPT Notification of Q3 Results and Audio Webcast
3rd Feb 20097:00 amRNSOPT announces new Chief Technology Officer
2nd Feb 20097:00 amRNSOPT Announces New Chief Executive Officer
26th Jan 20092:30 pmRNSOPT and Lockheed Martin wave power agreement
16th Jan 20097:05 amRNSDirector's Dealing
16th Jan 20097:00 amRNSAppointment of Nomad
19th Dec 20087:00 amRNSOPT and Leighton Contractors Sign Agreement
10th Dec 20087:00 amRNSOPT second quarter and six months results
3rd Dec 20082:48 pmRNSNotification of Q2 results and audiowebcast
12th Nov 20087:00 amRNSOPT launches new PowerBuoy in Hawaii
5th Nov 20087:00 amRNSOPT wins new $3m contract from US Navy
24th Oct 20083:27 pmRNSNASDAQ Audit Committee Rule Non-Compliance
16th Oct 20088:00 amRNSOPT Launches Powerbuoy for US Navy
13th Oct 20085:29 pmRNSDirector's Dealing
6th Oct 20084:16 pmRNSGrant and additional listing of shares
6th Oct 20084:13 pmRNSResult of AGM
2nd Oct 20087:00 amRNSOPT wins $2m award from US Department of Energy
23rd Sep 20087:00 amRNSOPT deploys first commercial PowerBuoy
9th Sep 20087:00 amRNS1st Quarter Results
5th Sep 20087:00 amRNSAnnual Meeting and Proxy Mate
2nd Sep 20087:00 amRNSNotification of Q1 results an
28th Jul 20087:00 amRNSOcean Power Technologies Secu
14th Jul 20087:00 amRNSFinal Results
7th Jul 20087:00 amRNSNotice of Results
7th Jul 20087:00 amRNSOPT to host audio webcast on
25th Jun 20085:08 pmRNSOPT to present at EnergyOcean
24th Jun 200811:29 amRNSGrant of Stock Options
19th May 20087:00 amRNSOPT signs Australian wave pow
25th Mar 20087:01 amRNSInvestor conf presentation
25th Mar 20087:01 amRNSOPT Spanish Project
17th Mar 20087:01 amRNS3rd Quarter Results
11th Mar 20084:39 pmRNSNotice of Webcast - amendment
11th Mar 20087:01 amRNSNotice of Audio Webcast
15th Jan 20087:01 amRNSGrant of stock options
3rd Jan 20087:00 amRNSOPT Appointment
17th Dec 20077:01 amRNSInterim Results
11th Dec 20074:49 pmRNSAudio Webcast
11th Dec 20079:37 amRNSNotice of Results
8th Nov 20077:02 amRNSOPT appoints new director
8th Nov 20077:02 amRNSAdditional LIsting of Shares
30th Oct 20077:01 amRNSOPT signs agreement
30th Oct 20077:00 amBUSOcean Power Technologies and Converteam Sign Exclusive Cooperation Agreement
10th Oct 20077:01 amRNSResult of AGM
2nd Oct 20077:01 amRNSOPT receives funding
2nd Oct 20077:00 amBUSOcean Power Technologies Receives Additional $1.9 Million Funding for US Navy Project
24th Sep 20077:02 amRNSAdditional listing of shares
17th Sep 20076:47 pmBUSOcean Power Technologies Announces Results for the Three Months Ended July 31, 2007
17th Sep 20075:40 pmRNS1st Quarter Results
11th Sep 20079:03 amBUSOcean Power Technologies to Host Audio Webcast on Quarterly Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.